The tumor suppressor gene CDKN2A, known to contribute to aggressive disease behavior when inactivated, [28,29,30,31,32,33] was significantly hypermethylated in DLBCL compared to controls (Figure 2F). The gene discussed is CDKN2A; the disease is diffuse large B-cell lymphoma.